Kanada - angleščina - Health Canada

pharmascience inc - cholestyramine resin - powder for suspension - 4g - cholestyramine resin 4g - bile acid sequestrants

Kanada - angleščina - Health Canada

pharmascience inc - cholestyramine resin - powder for suspension - 4g - cholestyramine resin 4g - bile acid sequestrants

Singapur - angleščina - HSA (Health Sciences Authority)

zyfas pharma pte ltd - cholestyramine resin (anhydrous) - powder - 4 g/sachet - cholestyramine resin (anhydrous) 4 g/sachet

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - cholestyramine -

Združene države Amerike - angleščina - NLM (National Library of Medicine)

eli lilly and company - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg - evista is indicated for the treatment and prevention of osteoporosis in postmenopausal women [see clinical studies (14.1, 14.2)] . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis [see clinical studies (14.3)] . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer [see clinical studies (14.4)] . the effect in the reduction in the incidence of breast cancer was shown in a study of postmenopausal women at high risk for breast cancer with a 5-year planned duration with a median follow-up of 4.3 years [see clinical studies (14.4)] . twenty-seven percent of the participants received drug for 5 years. the long-term effects and the recommended length of treatment are not known. high risk of breast cancer is defined as at least one breast biopsy showing lobular carcinoma in situ (lcis) or atypical hyperplasia, one or more first-degree relatives with breast cancer, or a 5-y

Armenija - angleščina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis pharma produktions gmbh - diclofenac-cholestyramine (diclofenac sodium) - capsules hard - 145,6mg (75mg)

Bahrajn - angleščina - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - cholestyramine - powder - 4

Kanada - angleščina - Health Canada

bristol labs division of bristol-myers squibb - cholestyramine resin - powder for solution - 4g - cholestyramine resin 4g - bile acid sequestrants

Kanada - angleščina - Health Canada

bristol labs division of bristol-myers squibb - cholestyramine resin - powder for solution - 4g - cholestyramine resin 4g - bile acid sequestrants

Kanada - angleščina - Health Canada

bristol labs division of bristol-myers squibb - cholestyramine resin - powder for solution - 4g - cholestyramine resin 4g - bile acid sequestrants